Mercury Pharmaceuticals

GC product division celebrates 70th anniversary, European and world premieres underscore progress in laboratory analytics

Shimadzu’s design craftech - Fusing traditional Kyoto craft techniques with industrial production

Shimadzu Corporation, which was celebrating its 150th anniversary in 2025, has a long history of involvement with traditional Kyoto crafts dating back to its origins as a maker of Buddhist altar fittings.

UPFs before conception may shape fertility and embryo growth

Findings show ultraprocessed food consumption before conception influences fertility and embryonic development, urging further research in this area.

Copper-based agent complex kills cancer cells in a novel way

​A copper-based agent complex kills cancer cells in a novel way. It receives its activation signal through light. It could help where existing chemotherapy treatments reach their limits.

Can AI chatbots help brain tumor patients understand their care?

Integrating LLMs in brain tumor care could enhance patient understanding, but requires strict oversight to manage risks and ensure reliable information.

WHO highlights growing inclusion of refugees in global health policies

The World Health Organization (WHO) reports a major shift in how countries are responding to the health needs of refugees and migrants, with new data showing more than 60 countries – two thirds of those surveyed – now include them in their national health policies and laws.

Taking a GLP-1? Doctors say not to forget about movement and mental health

Severe ankle pain drove Jelon Smart to start taking a weight loss injection a year and a half ago.

New fathers face delayed mental health risks after childbirth

Paternal mental health risks increase after childbirth, with delayed detection of psychiatric disorders underscoring the need for targeted support for fathers.

Championing innovation: Bedfont® Scientific CTO shortlisted for Technology Leader of the Year

Scott Deamer-Smith, Chief Technology Officer (CTO) at Bedfont® Scientific Limited, has been recognized for his outstanding contribution to innovation and technology.

Spear Bio introduces new ultra-sensitive neurodegenerative assays and expands direct access at AD/PD 2026

Spear Bio, an innovator in ultrasensitive protein biomarker detection, showcased three new SPEAR UltraDetect™ immunoassays—brain-derived p-Tau 217 (BD-pTau 217), α-synuclein (α-syn) and phospho-Ser129-α-synuclein (pS129-α-syn)—at the International Conference on Alzheimer’s & Parkinson’s Diseases (AD/PD 2026) last week.